7 results
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
for Treatment of Iron ... #Deficiency #Management ... Diagnosis #Algorithm #HFrEF ... #sCHF #HeartFailure ... #Indications #Treatment
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
, haemoglobin; HFrEF ... #Deficiency #Management ... #Diagnosis #HFrEF ... #sCHF #HeartFailure ... #Cardiology #Indications
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive ... ACCAHA #Algorithm #Management
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HFrEF #Pharmacology ... #Management #Treatment
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
HFrEF: Guideline ... American patients #hfref ... #management #medications ... #chf #cardiology ... #GDMT
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
hospitalization for the management ... Spironolactone #HFpEF ... #dCHF #Cardiology ... #EBM #VisualAbstract ... #Trial